health
Hosted by Jonathan Kaskey · health · EN-US
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
31%
Guest openness
Selective
Sign up to generate a grounded pitch for Pharma Sessions.
Signup to Generate a PitchPharma Sessions is hosted by Jonathan Kaskey. The show has published 61 episodes to date.
Recent episodes include "Data, AI, and the Future of Field Training with Annel Duckels from BMS" (24 September 2026, 17 minutes), "Hallway Interviews with Pharma Learning Leaders" (31 July 2026, 39 minutes), and "The Question Behind the Question - Field Training with Jennifer Muszik" (8 June 2026, 29 minutes).
Pharma Sessions publishes roughly weekly, with episodes averaging 31 minutes across 61 episodes.
Booking probability for Pharma Sessions is 31%, and the host is rated Selective on guests. Pharma Sessions requires a Pod Score of 80 or higher. Pharma Sessions's contact route on record: public web form.
The strongest fits for Pharma Sessions are Pharmaceuticals and Business & Management Consulting. Pharma Sessions has a health audience.
Jonathan Kaskey hosts Pharma Sessions, a health podcast with 61 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Pharma Sessions
In this episode, Jonathan sits down with Annel Duckels, who leads worldwide commercialization learning at Bristol Myers Squibb, to talk about modernizing pharma training through data and AI. Annel's unconventional path...
Episode #3
Pharma Sessions — ACTO Client Summit: Hallway Interviews At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and...
Episode #1
<p>What separates a good pharma sales rep from a great one? According to Jennifer Muszik, it's the ability to understand the question behind the question — the real need behind what a customer is asking.</p><p>In this...
Episode #32
<p>In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Frank Sorce, Chief Commercial Officer at UPM Pharmaceuticals, to share insights into the critical decisions involved in selecting contract...
Episode #31
<p>In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy's and St Thomas' NHS Foundation Trust, to talk about Open Medicine, a platform...
Episode #30
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery...
Episode #29
In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today...
Episode #28
Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate...
Episode #27
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss...
Episode #26
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO...
Episode #25
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug...
Episode #24
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares...
Episode #23
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters...
Episode #22
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons...
Episode #21
Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is...
Episode #20
In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After...
Episode #19
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too...
Episode #18
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too...
Episode #17
Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to...
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too...
Recent guests on Pharma Sessions. Study who booked and why before you pitch.
Senior Director of AI Innovation, Interfaith Center on Corporate Responsibility
Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, Missouri Bankers Association
former Secretary of the United States Department of Veterans Affairs, U.S. Department of Veterans Affairs
Bristol Myers Squibb
PitchCentric classifies Pharma Sessions under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
